Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: We examined the epistatic effect between haplotypes of glycogen synthase kinase‐3 β (GSK3B) gene and microtubule‐associated protein Tau (MAPT) gene in Alzheimer's disease (AD). Methods: A genetic association study of three AD cohorts was made. Linear regression analyses were used to examine effects of MAPT polymorphisms on gene expression and alternative splicing. β‐Catenin levels and signaling were determined using Western blot and luciferase reporter assays in cells transfected with a combination of GSK3B and MAPT complementary DNA. Results: Consistent interaction between GSK3B and MAPT genes in three late‐onset AD cohorts was observed, with the GSK3B haplotype (T‐T) significantly increasing the risk for AD in individuals with at least one H2 haplotype (odds ratio, 1.68–2.33; p = 0.005–0.036). The GSK3B haplotype was significantly protective in the Chinese cohort (odds ratio, 0.33; p = 0.016), after adjusting for the effect of age and sex. There are significant differences in in vivo transcriptional efficiency between the two MAPT haplotypes (H1 and H2) as determined by measurement of cerebellar transcripts (p < 0.001). Overexpression of either MAPT or GSK3B resulted in decreased β‐catenin levels compared with a control vector (p < 0.001). Conversely, cotransfection of both of these molecules increased β‐catenin signaling. Interpretation: Our genetic and biochemical analyses have identified a novel interaction between Tau and GSK‐3β in late‐onset AD causative factors. Our data are consistent with an epistatic model of interaction where discordant levels of GSK3B and MAPT gene expression can lead to altered β‐catenin levels and pathogenicity. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Stanford, P. M., Halliday, G. M., Brooks, W. S., Kwok, J. B. J., Storey, C. E., Creasey, H., Morris, J. G. L., Fulham, M. J., & Schofield, P. R. (2000) · Brain · doi:10.1093/brain/123.5.880 · Cited by 262
Self-citationChenn, A. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.6.599 · Cited by 253 · cited 1×
“Overexpression of -catenin in transgenic mice resulted in increased neuronal production leading to enlarged forebrains and altered neuronal migration during embryonic development.(33) Conversely, conditional knockout of -catenin resulted in increased neuronal apoptosis and absence of the midbrain and hindbrain in tran…”
BackgroundGSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · cited 10×
“The splice isoform has an increased ability to phosphorylate Tau, and thus is likely to be a pathogenic isoform.(19) Consistent with the effect of the GSK3B T-T haplotype in the white PD cohort, we observed that there is an increased risk for AD in individuals who are homozygous for the T-T haplotype and at least one…”
BackgroundMethodResultSelf-citationSingle molecule profiling of tau gene expression in Alzheimer’s disease
Conrad, C., Zhu, J., Conrad, C., Schoenfeld, D., Fang, Z., Ingelsson, M., Stamm, S., Church, G., & Hyman, B. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04857.x · Cited by 68
Mateo, I., Infante, J., Llorca, J., Rodríguez, E., Berciano, J., & Combarros, O. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091044 · Cited by 53
Cited by
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
del Ser, T., Steinwachs, K. C., Gertz, H. J., Andrés, M. V., Gómez-Carrillo, B., Medina, M., Vericat, J. A., Redondo, P., Fleet, D., & León, T. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120805 · Cited by 329
Targeting protein kinases in central nervous system disorders
Chico, L. K., Van Eldik, L. J., & Watterson, D. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2999 · Cited by 298
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Domínguez, J. M., Fuertes, A., Orozco, L., del Monte-Millán, M., Delgado, E., & Medina, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306472 · Cited by 246
“It suggests that the accumulation of the amyloid peptide is the primary factor that triggers a cascade of pathogenic events leading to alterations in Tau protein, synaptic dysfunction, and neuronal death (2).”
BackgroundInfluentialMolecular mechanisms of neuropathological changes in Alzheimer’s disease: a review
Šerý, O., Povová, J., Míšek, I., Pešák, L., & Janout, V. (2013) · Folia Neuropathologica · doi:10.5114/fn.2013.34190 · Cited by 190
“It was demonstrated that the MAPT gene rs242557 polymorphism that is part of the H1c subhaplotype, re sults in increased MAPT gene expression [34].”
Background
Metadata
- Authors
- Kwok, J. B. J., Loy, C. T., Hamilton, G., Lau, E., Hallupp, M., Williams, J., Owen, M. J., Broe, G. A., Tang, N., Lam, L., Powell, J. F., Lovestone, S., & Schofield, P. R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-10
- Volume
- 64
- Issue
- 4
- Pages
- 446-454
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1971859296
- Cited by
- 78
- References
- 8
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.21476
- The paper
- Kwok, J. B. J., Loy, C. T., Hamilton, G., Lau, E., Hallupp, M., Williams, J., Owen, M. J., Broe, G. A., Tang, N., Lam, L., Powell, J. F., Lovestone, S., & Schofield, P. R. (2008). Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.21476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.